Clinical Software Firm etrials Turns A Profit

etrials

(Nasdaq: ETWC), a provider of "eClinical" software and services for uses in clinical trials, moved into the black in the second quarter.

Boosted by an 11 percent growth in revenues to $4.2 million from a year ago, etrials posted a profit of $60,746. The company lost $101,627 in the same period in 2005.

The company now has 38 customers, up from 23 a year ago, and is working with 114 clinical trials. That's up from 102 in 2005.

"We are very pleased with our second quarter results and remain on track for a profitable year, before non-cash stock compensation expenses," said John Cline, chief executive officer of etrials.